Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Effect of chronic amiodarone therapy on defibrillation energy requirements in humans.

Pelosi F Jr, Oral H, Kim MH, Sticherling C, Horwood L, Knight BP, Michaud GF, Morady F, Strickberger SA.

J Cardiovasc Electrophysiol. 2000 Jul;11(7):736-40.

PMID:
10921789
[PubMed - indexed for MEDLINE]
2.

Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements.

Daoud EG, Man KC, Horwood L, Morady F, Strickberger SA.

Am J Cardiol. 1997 Jan 1;79(1):97-100.

PMID:
9024750
[PubMed - indexed for MEDLINE]
3.

Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.

Kühlkamp V, Mewis C, Suchalla R, Mermi J, Dörnberger V, Seipel L.

Int J Cardiol. 1999 Jun 1;69(3):271-9.

PMID:
10402110
[PubMed - indexed for MEDLINE]
4.

Long-term evaluation of the ventricular defibrillation energy requirement.

Tokano T, Pelosi F, Flemming M, Horwood L, Souza JJ, Zivin A, Knight BP, Goyal R, Man KC, Morady F, Strickberger SA.

J Cardiovasc Electrophysiol. 1998 Sep;9(9):916-20.

PMID:
9786072
[PubMed - indexed for MEDLINE]
5.

Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices.

Echt DS, Gremillion ST, Lee JT, Roden DM, Murray KT, Borganelli M, Crawford DM, Stewart JR, Hammon JW.

J Cardiovasc Electrophysiol. 1994 Sep;5(9):752-60.

PMID:
7827714
[PubMed - indexed for MEDLINE]
6.

Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ.

Circulation. 2006 Jul 11;114(2):104-9. Epub 2006 Jul 3.

PMID:
16818810
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.

Dorian P, Newman D, Harris L, Downar E.

Can J Cardiol. 1994 Mar;10(2):193-200.

PMID:
8143220
[PubMed - indexed for MEDLINE]
9.

Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks.

Szili-Torok T, Theuns D, Verblaauw T, Scholten M, Kimman GJ, Res J, Jordaens L.

Acta Cardiol. 2002 Oct;57(5):329-34.

PMID:
12405569
[PubMed - indexed for MEDLINE]
10.

Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator.

Strickberger SA, Daoud EG, Davidson T, Weiss R, Bogun F, Knight BP, Bahu M, Goyal R, Man KC, Morady F.

Circulation. 1997 Aug 19;96(4):1217-23.

PMID:
9286952
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.

Leong-Sit P, Gula LJ, Diamantouros P, Krahn AD, Skanes AC, Yee R, Klein GJ.

Am Heart J. 2006 Dec;152(6):1104-8.

PMID:
17161062
[PubMed - indexed for MEDLINE]
12.

Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone.

Köbe J, Reinke F, Dechering DG, Breithardt G, Eckardt L.

Clin Res Cardiol. 2012 Mar;101(3):185-90. doi: 10.1007/s00392-011-0379-z. Epub 2011 Nov 5.

PMID:
22057653
[PubMed - indexed for MEDLINE]
13.

Effects of chronic amiodarone therapy on defibrillation threshold.

Jung W, Manz M, Pizzulli L, Pfeiffer D, Lüderitz B.

Am J Cardiol. 1992 Oct 15;70(11):1023-7.

PMID:
1414899
[PubMed - indexed for MEDLINE]
14.

A prospective evaluation of two defibrillation safety margin techniques in patients with low defibrillation energy requirements.

Strickberger SA, Man KC, Souza J, Zivin A, Weiss R, Knight BP, Goyal R, Daoud EG, Morady F.

J Cardiovasc Electrophysiol. 1998 Jan;9(1):41-6.

PMID:
9475576
[PubMed - indexed for MEDLINE]
15.

Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold.

Zhou L, Chen BP, Kluger J, Fan C, Chow MS.

J Am Coll Cardiol. 1998 Jun;31(7):1672-8.

PMID:
9626850
[PubMed - indexed for MEDLINE]
Free Article
16.

Use of multiple patches during implantation of epicardial defibrillator systems.

Baerman JM, Blakeman BP, Olshansky B, Kopp DE, Kall JG, Wilber DJ.

Am J Cardiol. 1993 Jan 1;71(1):68-71.

PMID:
8420238
[PubMed - indexed for MEDLINE]
17.

Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.

Candinas R, Frielingsdorf J, Ha HR, Carrel T, Turina M, Follath F.

Eur J Clin Pharmacol. 1998 Jan;53(5):331-6.

PMID:
9516032
[PubMed - indexed for MEDLINE]
18.

Effects of antiarrhythmic drugs on epicardial defibrillation energy requirements and the rate of defibrillator discharges.

Jung W, Manz M, Pfeiffer D, Tebbenjohanns J, Pizzulli L, Lüderitz B.

Pacing Clin Electrophysiol. 1993 Jan;16(1 Pt 2):198-201.

PMID:
7681571
[PubMed - indexed for MEDLINE]
19.

High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol.

Boriani G, Biffi M, Frabetti L, Maraschi M, Branzi A.

Heart Lung. 2000 Nov-Dec;29(6):412-6.

PMID:
11080321
[PubMed - indexed for MEDLINE]
20.

Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.

Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Swiatecka G.

Kardiol Pol. 2005 Apr;62(4):317-28; discussion 329-31. English, Polish.

PMID:
15928737
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk